Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Cipher Pharmaceuticals Inc. T.CPH

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  CPHMF | CPHR

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with three commercial products and fourth in development, which are improved formulations of marketed drugs.
Price: $15.65 | Change: +$0.04 | %Change: +0.26%
Volume: 57,595 | Day High/Low: 15.69/15.34 | 52 Week High/Low: 16.28/6.75
View modes: 
0 stars

RE:A big Q 4 2014 sales incr will send stock price to $20.00

When I say Absorbica sales may increase by as much as 4% in the USA in the 4th quarter of 2014,  I mean going from about 20% USA market share to 24% market share. The analysists have factored in...read more
0 stars

RE:Kisu biosyent good company but way overbought

Sold my RX holdings on the upswing yesterday.  Your PE estimate seems correct based on their last qtr earnings and if revenue does not increase dramatically the price could float down considerably.   ...read more
0 stars

Kisu biosyent good company but way overbought

If everything goes perfectly for them they may bring their PE down to 30 from 50, 3 years from now after all their new product launches. Biosyent has no liquidity compared to Cipher. Biosyent has...read more
0 stars

A big Q 4 2014 sales incr will send stock price to $20.00

There is a lot of upside to this stock now. The analysists have not factored in any increase in sales from the new sales push by Ranbaxy for Absorbica in the USA market (new dosages etc.). I think...read more
0 stars

Piper Jaffrey

Nice to see Cipher presenting at the Piper Jaffrey Healthcare Conf Dec. 2.  US growth and momentum investors should be well represented here.  This new team is showing considerably better market...read more
0 stars

RE:nice to see nasdaq listing

Might have to wait for the bell ringing on Dec 3 before anyone notices the Nasdaq listing.  Currently a $3+ spread between bid and ask with no shares traded.  rate and reply
0 stars

nice to see nasdaq listing

our tsx symbol also changed to cph from dnd. cheers, dave.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:The average PE on the Nazdaq is much higher than on the TSX

$13 was mid trend.  Fibs not withstanding, there's been no actual support or resistance at that level.  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:The average PE on the Nazdaq is much higher than on the TSX

I am going to wait it out too. Are you using the Fibonacci to guage the retracement ? I show the .618 Fib right at the $13 level. It would be nice to pick some up for that price.  rate and reply
0 stars

RE:RE:RE:RE:RE:The average PE on the Nazdaq is much higher than on the TSX

I think you may have another chance as chart looks like we retrace back to around $13 before heading higher. Also I think US Institutions and Hedge funds who want to own this they will drop the price...read more
0 stars

RE:RE:RE:RE:The average PE on the Nazdaq is much higher than on the TSX

Ya I know, I wish I had bought more when it was at $11 not too long ago. My original lot is at $8  rate and reply
0 stars

RE:Don't see the new Naz CPHR symbol or new TSX CPH symbol?

CPHR  12.85 - 13.62 US  rate and reply
0 stars

Don't see the new Naz CPHR symbol or new TSX CPH symbol?

Thought they were to be active at today's open?  rate and reply
0 stars

RE:RE:RE:The average PE on the Nazdaq is much higher than on the TSX

Im astonished at how this refuses to drop below $15. Maybe you'll get high 14s intraday but it just doesnt stay there. Thats some great support. I think 20 will be attainable very easily and that $30...read more
0 stars

RE:RE:The average PE on the Nazdaq is much higher than on the TSX

Let it fall some more, I am looking to add to my position. This will be a $20 stock in the next 12 months. Its trading at an attractive multiple now but it would be nice to get it for around $14. GLTA  rate and reply
0 stars

RE:RE:The average PE on the Nazdaq is much higher than on the TSX

Actually, just 600 shares traded and a wide spread between bid and ask.  rate and reply
0 stars

RE:The average PE on the Nazdaq is much higher than on the TSX

RX big fall didn't happen today on the announcement of another product release. Meanwhile it seems that DND is selling off on the Nasdaq - perhaps the Nasdaq makes it easier to short DND. I wonder if...read more
0 stars

RE:The average PE on the Nazdaq is much higher than on the TSX

Why not own a basket of stocks in the sector as I do (eg. DND, GUD, CXR, PHM and yes even Biosyent). They should all do well.  GLTA  rate and reply
0 stars

The average PE on the Nazdaq is much higher than on the TSX

Just look at the price per share earnings multiples of the average company on the NAZDAQ compared to Cipher, to see if Cipher can do better on the NAZDAQ. KISU is a Biosyent pumper their PE is around...read more
3 stars

RE:RE:RE:RE:Nazdaq listing at same time as Ranbaxy Absorbica sales push

What makes you think the TSX is holding it back???  Not much excitment about the Nasdaq listing today so far.  rate and reply